Gilteritinib in the management of acute myeloid leukemia: Current evidence and future directions-Reference-Cited by-同舟云学术

Gilteritinib in the management of acute myeloid leukemia: Current evidence and future directions

Published:2022-03 Issue: Volume:114 Page:106808
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Nuhoğlu Kantarcı Eda,Eşkazan Ahmet Emre

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference63 articles.

1. Acute myeloid leukaemia;Short;Lancet,2018

2. National Cancer Institute. Surveillance, Epidemiology, and End Results Program, Stat fact sheets: Acute myeloid leukemia. http://seer.cancer.gov/statfacts/html/amyl.html (Accessed 14 December 2021).

3. Oral adherence in adults with acute myeloid leukemia (AML): results of a mixed methods study;Bryant;Support. Care Cancer,2020

4. Novel therapies in acute myeloid leukemia;Mukherjee;Semin. Oncol. Nurs.,2019

5. New drugs approved for acute myeloid leukaemia in 2018;Kucukyurt;Br. J. Clin. Pharmacol.,2019

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting oncogenic kinases: Insights on FDA approved tyrosine kinase inhibitors;European Journal of Pharmacology;2024-05

2. FLT3 and IDH1/2 Inhibitors for Acute Myeloid Leukemia: Focused Clinical Narrative Review of Forthcoming Drugs from an Indian Context;Indian Journal of Medical and Paediatric Oncology;2024-02-09

3. A comparative safety review of targeted therapies for acute myeloid leukemia;Expert Opinion on Drug Safety;2023-12-02

4. dSTORM‐Based Single‐Cell Protein Quantitative Analysis Can Effectively Evaluate the Degradation Ability of PROTACs;ChemBioChem;2023-01-24

5. New Targeted Drugs for Acute Myeloid Leukemia and Antifungals: Pharmacokinetic Challenges and Opportunities;Chemotherapy;2023